If you haven`t bought the previous dip in MDT:
Then analyzing the options chain and the chart patterns of MDT Medtronic plc prior to the earnings report this week,
I would consider purchasing the 75usd strike price at the money Calls with
an expiration date of 2023-11-24,
for a premium of approximately $1.24.
If these options prove to be profitable prior to the...
Looking at the MDT Medtronic options chain ahead of earnings , i would buy the $82.5 strike price Calls with
2023-1-20 expiration date for about
$2.93 premium.
If the options turn out to be profitable Before the earnings release, i would sell at least 50%.
Looking forward to read your opinion about it.
Goals 199, 190, 185. Invalidation at 230.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that...
The chart speaks for itself. 100sma has been held and tested multiple times.
RSI has not gone below 35 RSI.
Giving it a little wiggle room makes sense to avoid getting stopped out. The ATR (average true range) is 2 points. So a stop below $127 could potentially provide enough room.
As I said in my previous post I didn't think MDT should be moving so fast. We had a nice run up but all good things need to take a break. Momentum is still bullish.
After some conversation with a young single mom and what she goes through to get her and her 2 yr old diabetes meds @ $13hr...f to the big pharma and f to the health care that does not cover such a life saving drug. It's not a conspiracy...it's a cultural failure to recognize how far we have come in such a short time. Some will call it profiteering...sure but it's...
NASDAQ:TMDI
AMEX:TRXC
These symbols have been on a similar path throughout the year. From November to the beginning of January, $TRXC price action lagged a few days behind $TMDI. Since January $TMDI appears to be the follower. Watching price action of $TRXC when it reaches the yellow ellipse may give us an idea of how $TMDI will eventually exit this channel....
Medtronic Plc has recently agreed to acquire all outstanding shares of spinal surgery device maker, Medicrea at €7.00/share, representing a 22% premium over Friday's closing price. This merger and acquisition has driven the share price to move up as well as giving the stock a promising future amidst the advent of second wave of the pandemic which most of the...
Healthcare has been a leader YTD, as it has the defensive nature and is gaining momentum on the spread and containment of the COVID. Also, negative sentiment of the healthcare sector regarding the opioid crisis (which seems like a long time ago now), and politicians creating regulations for insurance reform; has now subsided.
Inside the XLV, IHI (medical devices)...
With the market down today, MDT doesn't care... It's breaking tested, heavy resistance at all time highs.
Technicals look great as well.
*Check chart for more info*
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable...
